Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo study (original) (raw)

Implications of tissue transglutaminase expression in malignant melanoma

Kapil Mehta

Molecular Cancer Therapeutics, 2006

View PDFchevron_right

Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines

Guido Swart

International Journal of Cancer, 2006

View PDFchevron_right

Distinct protein expression and activity of transglutaminases found in different epidermal tumors

Chika Ohata

Experimental Dermatology, 2014

View PDFchevron_right

Tissue transglutaminase promotes or suppresses tumors depending on cell context

Kapil Mehta

Anticancer research, 2009

View PDFchevron_right

The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression

Simone Beninati

Medical Sciences

View PDFchevron_right

The Outside-In Journey of Tissue Transglutaminase in Cancer

Livia E. Sima

Cells

View PDFchevron_right

Tissue transglutaminase: a new target to reverse cancer drug resistance

Alfredo Budillon

Amino Acids, 2013

View PDFchevron_right

Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells

Roberto Braglia, Bruno Provenzano, Marzia Nuccetelli, Cinzia Forni

Amino Acids, 2009

View PDFchevron_right

Transglutaminases: key regulators of cancer metastasis

Simone Beninati

Amino Acids, 2012

View PDFchevron_right

The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells

Jens Pietzsch

Cells

View PDFchevron_right

Tissue transglutaminase-mediated chemoresistance in cancer cells

Amit Verma

Drug Resistance Updates, 2007

View PDFchevron_right

Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth

Martin Griffin

Cell Death and Differentiation, 2006

View PDFchevron_right

Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?

SANTOSH KUMAR

Amino Acids, 2013

View PDFchevron_right

Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer

Kapil Mehta

Clinical Cancer Research, 2004

View PDFchevron_right

121 LOSS OF TRANSGLUTAMINASE 2 (TG2) ACTIVITY PROMOTES RENAL CELL CARCINOMA (RCC)

Fikrettin Şahin

The Journal of Urology, 2011

View PDFchevron_right

Isolation of a cDNA Encoding a Novel Member of the Transglutaminase Gene Family from Human Keratinocytes

Daniel Aeschlimann

Journal of Biological Chemistry, 1998

View PDFchevron_right

A Novel Tumor Suppressor Protein Promotes Keratinocyte Terminal Differentiation via Activation of Type I Transglutaminase

Ann-Marie Broome

Journal of Biological Chemistry, 2003

View PDFchevron_right

Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies

Richard Presland

Journal of Dermatological Science, 2003

View PDFchevron_right

Isolation of a cDNA Encoding a Novel Member of the Transglutaminase Gene Family from Human Keratinocytes. DETECTION AND IDENTIFICATION OF TRANSGLUTAMINASE GENE PRODUCTS BASED ON REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION WITH DEGENERATE PRIMERS

Daniel Aeschlimann

Journal of Biological Chemistry, 1998

View PDFchevron_right

Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion

Kapil Mehta

2005

View PDFchevron_right

Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells

Kapil Mehta

PLoS ONE, 2010

View PDFchevron_right

Biological Functionalities of Transglutaminase 2 and the Possibility of Its Compensation by Other Members of the Transglutaminase Family

Benedict Odii

The Scientific World Journal, 2014

View PDFchevron_right

Role of Transglutaminase 2 in Migration of Tumor Cells and How Mouse Models Fit

Ajna Bihorac

Medical Sciences

View PDFchevron_right

Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer

SANTOSH KUMAR

Breast Cancer Research, 2012

View PDFchevron_right

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype

Nicoletta Bianchi

International Journal of Molecular Sciences

View PDFchevron_right

Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells

Chithan Kandaswami, Jiuan-Jiuan Hwang

Molecular Cancer, 2011

View PDFchevron_right

Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells

Kapil Mehta

Oncogene, 2006

View PDFchevron_right

Transglutaminase Regulation of Cell Function

Alexey Belkin

Physiological Reviews, 2014

View PDFchevron_right

Transglutaminase 2: A molecular Swiss army knife

Janusz Tucholski

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012

View PDFchevron_right

Increased Expression of Tissue Transglutaminase in Pancreatic Ductal Adenocarcinoma and Its Implications in Drug Resistance and Metastasis

Amit Verma

Cancer Research, 2006

View PDFchevron_right

Type I Keratinocyte Transglutaminase: Expression in Human Skin and Psoriasis

Scott Thacher

Journal of Investigative Dermatology, 1992

View PDFchevron_right

Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells

SANTOSH KUMAR

Breast Cancer Research, 2012

View PDFchevron_right